ISoOR Insight Team 2026. Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025. Journal of Organoid and Bioscience. 3, 1 (Mar. 2026).